Mun N. Hui

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Network Integrated Platform for Clinical Trials Navigation from the New South Wales Early Phase Clinical Trials Alliance.

Network Integrated Platform for Clinical Trials Navigation from the New South Wales Early Phase Clinical Trials Alliance.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 02, 2026

A phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumours.

A phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumours.

Journal: BMJ open

Published: May 02, 2025

GFH018 and Toripalimab Combination Therapy for Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: Results from a Phase Ib/II Study.

GFH018 and Toripalimab Combination Therapy for Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: Results from a Phase Ib/II Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 13, 2025

Curative-intent tri-modality treatment of de novo bone-only oligometastatic breast cancer: single-center patient outcomes.

Curative-intent tri-modality treatment of de novo bone-only oligometastatic breast cancer: single-center patient outcomes.

Journal: BMC cancer

Published: October 30, 2024

Corrigendum: Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein.

Corrigendum: Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein.

Journal: Frontiers in immunology

Published: June 01, 2024

Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein.

Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein.

Journal: Frontiers in immunology

Published: November 27, 2023

Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group.

Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group.

Journal: ESMO open

Published: December 10, 2022

Patient satisfaction with telehealth consultations in medical oncology clinics: A cross-sectional study at a metropolitan centre during the COVID-19 pandemic.

Patient satisfaction with telehealth consultations in medical oncology clinics: A cross-sectional study at a metropolitan centre during the COVID-19 pandemic.

Journal: Journal of telemedicine and telecare

Published: October 18, 2021

Novel Clinician-Lead Intervention to Address Fear of Cancer Recurrence in Breast Cancer Survivors.

Novel Clinician-Lead Intervention to Address Fear of Cancer Recurrence in Breast Cancer Survivors.

Journal: JCO oncology practice

Published: February 11, 2021

Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models.

Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models.

Journal: Breast cancer research : BCR

Published: February 02, 2021

A single-cell and spatially resolved atlas of human breast cancers.

A single-cell and spatially resolved atlas of human breast cancers.

Journal: Nature genetics

Published: September 11, 2020

The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer.

The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer.

Journal: Nature medicine

Published: August 20, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026